Physician profile
Mandy L Lanier
NPI 1902949258
$844.80
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $40.74 · 2021: $83.76 · 2022: $66.48 · 2023: $271 · 2024: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $124.07 | 2019-2024 | Cequa |
| Alcon Vision LLC | $91.91 | 2023-2024 | Total30, Dailies Total1, Simbrinza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $91.03 | 2019 | |
| Abbvie INC. | $72.52 | 2023 | |
| Novartis Pharmaceuticals Corporation | $65.37 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $60.64 | 2024 | Vyzulta, Miebo, Xiidra |
| Mallinckrodt Hospital Products INC. | $57.06 | 2022-2024 | Acthar |
| Allergan, INC. | $51.16 | 2021 | |
| Kala Pharmaceuticals, INC. | $32.22 | 2019-2021 | |
| Harrow Eye, LLC | $28.93 | 2024 | Vevye |
| Johnson & Johnson Vision Care, INC. | $28.17 | 2020 | |
| Dompe US, INC. | $25.52 | 2024 | Oxervate |
| Aerie Pharmaceuticals, INC. | $24.88 | 2019 | |
| Thea Pharma INC. | $24.33 | 2023 | |
| Oyster Point Pharma, INC. | $18.60 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $18.31 | 2019 | |
| Coopervision INC. | $17.51 | 2024 | Onefit Contact Lens |
| Omeros Corporation | $12.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Lanier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.